123 related articles for article (PubMed ID: 38838028)
1. Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
Achilles SL; Kelly CW; Hoesley CJ; Blithe DL; Brown J; Richardson BA; Devlin B; Hendrix CW; Poloyac SM; Marzinke MA; Gundacker H; Singh D; Piper JM; Johnson S; Steytler J; Chen BA;
PLoS One; 2024; 19(6):e0304552. PubMed ID: 38838028
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
Liu AY; Dominguez Islas C; Gundacker H; Neradilek B; Hoesley C; van der Straten A; Hendrix CW; Beamer M; Jacobson CE; McClure T; Harrell T; Bunge K; Devlin B; Nuttall J; Spence P; Steytler J; Piper JM; Marzinke MA;
J Int AIDS Soc; 2021 Jun; 24(6):e25747. PubMed ID: 34118115
[TBL] [Abstract][Full Text] [Related]
3. Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
Chen BA; Zhang J; Gundacker HM; Hendrix CW; Hoesley CJ; Salata RA; Dezzutti CS; van der Straten A; Hall WB; Jacobson CE; Johnson S; McGowan I; Nel AM; Soto-Torres L; Marzinke MA;
Clin Infect Dis; 2019 Mar; 68(7):1144-1151. PubMed ID: 30289485
[TBL] [Abstract][Full Text] [Related]
4. Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.
Chen BA; Panther L; Marzinke MA; Hendrix CW; Hoesley CJ; van der Straten A; Husnik MJ; Soto-Torres L; Nel A; Johnson S; Richardson-Harman N; Rabe LK; Dezzutti CS
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):242-9. PubMed ID: 26034880
[TBL] [Abstract][Full Text] [Related]
5. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK
Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275
[TBL] [Abstract][Full Text] [Related]
6. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.
Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N
AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365
[TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
Thurman AR; Brache V; Cochon L; Ouattara LA; Chandra N; Jacot T; Yousefieh N; Clark MR; Peet M; Hanif H; Schwartz JL; Ju S; Marzinke MA; Erikson DW; Parikh U; Herold BC; Fichorova RN; Tolley E; Doncel GF
PLoS One; 2022; 17(10):e0275794. PubMed ID: 36215267
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.
Bunge KE; Levy L; Szydlo DW; Zhang J; Gaur AH; Reirden D; Mayer KH; Futterman D; Hoesley C; Hillier SL; Marzinke MA; Hendrix CW; Gorbach PM; Wilson CM; Soto-Torres L; Kapogiannis B; Nel A; Squires KE;
J Acquir Immune Defic Syndr; 2020 Feb; 83(2):135-139. PubMed ID: 31929401
[TBL] [Abstract][Full Text] [Related]
9. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
[TBL] [Abstract][Full Text] [Related]
10. A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010).
Cranston RD; Hoesley C; Carballo-Diéguez A; Hendrix CW; Husnik M; Levy L; Hall W; Soto-Torres L; Nel AM
AIDS Res Hum Retroviruses; 2014 Feb; 30(2):184-9. PubMed ID: 24070431
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring.
Noguchi LM; Hoesley C; Kelly C; Scheckter R; Bunge K; Nel A; Marzinke MA; Hendrix CW; Dezzutti CS; Hillier SL; Bogen DL; Piper JM; Beigi RH
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602513
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya.
Mugo NR; Mudhune V; Heffron R; Thomas KK; McLellan-Lemal E; Njoroge B; Peacock S; O'Connor SM; Nyagol B; Ouma E; Ridzon R; Wiener J; Isoherranen N; Erikson DW; Ouattara LA; Yousefieh N; Jacot TA; Haaland RE; Morrison SA; Haugen HS; Thurman AR; Allen SA; Baeten JM; Samandari T; Doncel GF
Front Reprod Health; 2023; 5():1118030. PubMed ID: 37383290
[TBL] [Abstract][Full Text] [Related]
13. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF
PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
Cranston RD; Brown E; Bauermeister J; Dunne EF; Hoesley C; Ho K; Johnson S; Lucas J; Dominguez-Islas C; Gundacker H; Peda M; Jacobson CE; Kramzer L; Singh D; Dezzutti CS; Kunjara Na Ayudhya RP; Brand RM; Wang L; Marzinke MA; Piper J; Devlin B; Nuttall J; McGowan I; Hendrix CW
AIDS Res Hum Retroviruses; 2022 Apr; 38(4):257-268. PubMed ID: 34498980
[TBL] [Abstract][Full Text] [Related]
15. Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States.
Liu AY; Gundacker H; Richardson B; Chen BA; Hoesley C; van der Straten A; Brown A; Beamer M; Robinson J; Jacobson CE; Scheckter R; Bunge K; Schwartz J; Thurman A; Piper JM; Marzinke MA;
J Int AIDS Soc; 2024 Mar; 27(3):e26223. PubMed ID: 38444118
[TBL] [Abstract][Full Text] [Related]
16. Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.
Liu AY; Zhang J; Anderson PL; Wagner T; Pan Z; Peda M; Gomez K; Beamer M; Jacobson C; Strizki J; Dezzutti CS; Piper JM;
Clin Infect Dis; 2019 Mar; 68(7):1129-1135. PubMed ID: 30289444
[TBL] [Abstract][Full Text] [Related]
17. MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel.
Ho K; Dominguez-Islas C; Szydlo D; Edick S; Macagna N; Riddler SA; Brand RM; Jacobson CE; Kramzer L; Kunjara Na Ayudhya RP; Piper J; Marzinke MA; Bauermeister J; Nuttall J; Hillier SL; Hendrix CW
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0081622. PubMed ID: 36255254
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
19. The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides.
Holt JD; Cameron D; Dias N; Holding J; Muntendam A; Oostebring F; Dreier P; Rohan L; Nuttall J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3761-70. PubMed ID: 25845860
[TBL] [Abstract][Full Text] [Related]
20. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
Nel A; Bekker LG; Bukusi E; Hellstrӧm E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C
PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
